Keynote Lecture
Professor David Argyle BVMS PhD DECVIM-CA (Oncology) MRCVS
State of the Art Lecture: Treatment of Skin Tumours
Prof David Argyle completed a PhD in oncology and immunology at the University of Glasgow Veterinary School and then joined the Department of Veterinary Clinical Studies as lecturer and then senior lecturer in clinical oncology and gene therapy. In 2002, he became head of veterinary oncology at the University of Wisconsin-Madison, USA. In 2005 he returned to the UK to be appointed to the William Dick Chair of veterinary clinical studies at the University of Edinburgh and the head of the veterinary oncology and companion animal stem cell programme. He is an RCVS and European recognized specialist in Veterinary Oncology, a Diplomat of the European College of Internal Medicine in Oncology and is the co-scientific editor of the Journal of Veterinary and Comparative Oncology. His current major research interests are cancer biology and cancer stem cells.
Professor Richard L. Gallo MD PhD
State of the Art Lecture: Antimicrobial Peptides and the Skin
Dr. Gallo is a Professor of Medicine and Pediatrics and Chief of the Division of Dermatology at the University of California-San Diego. His research focuses on the role of the innate immune system in skin health and disease, focusing on antimicrobial peptides and aspects of the basic functions of the skin immune system. Key contributions by his laboratory have included the first discovery of the existence of antimicrobial peptides in mammalian skin and the first demonstration that these are essential for immune defence of mammals. A common them throughout his work has been application of a wide range of modern biochemical and molecular techniques in experimental systems designed to uncover basic aspect of human immunity. Dr. Gallo has been President of the Society of VA Dermatologists and serves on the Board of Directors of the American Professors of Dermatology and the Society for Investigative Dermatology Journal.
Dr. Robert Harman DVM MPVM
State of the Art Lecture: Stem Cell Therapy in Veterinary Dermatology – Scientific Evidence and Clinical Approach
Dr. Harman received his DVM from the University of California at Davis in 1982 and also concurrently completed a Masters in Preventative Veterinary Medicine through the Department of Epidemiology, UC Davis. Dr. Harman practiced in production animal medicine in California from 1982-1985. He then founded HTI Bio-Services, a contract veterinary research company. From 1985-1999, he was the senior clinical investigator and CEO of HTI Bio-Services and authored more than 500 study reports in support of the FDA and USDA registration of pharmaceuticals, biologics and medical devices. In 2003 he founded Vet-Stem, a veterinary regenerative medicine company in California. Dr. Harman has been the author on six peer-reviewed stem cell publications in veterinary and human medicine and has spoken at over 100 domestic and international conferences on the science and clinical translation of regenerative medicine.
Dr. Koji Nishifuji DVM PhD Dip AICVD
State of the Art Lecture: SkinWars: Episode I - Rampart of Horny Layer in Mammalian Skin
Dr Nishifuji gained a PhD from the United Graduate School of Veterinary Sciences, Gifu University and became a postdoctoral research fellow in the Department of Dermatology, Keio University School of Medicine. From 2007 to 2009 he was a Senior Assistant Professor, Department of Veterinary Medicine, Tokyo University of Agriculture and Technology and is currently an Associate Professor at the same institution. He is a de facto specialist of the Asian College of Veterinary Dermatology and the current Vice President of the Asian Society of Veterinary Dermatology; an Executive Board Member of the Japanese Society of Veterinary Dermatology; an Editorial Board Member of Veterinary Dermatology and an Associate Editor of the Japanese Journal of Veterinary Dermatology. His areas of special interest in research include stratum corneum lipids and cutaneous barrier function in dogs; desmosomal adhesion and related-skin diseases in mammals and tissue regeneration of canine epidermis
Professor J Scott Weese DVM DVSc Dip ACVIM
State of the Art Lecture: The Skin Microbiome in Heath and Disease
Dr. Weese is a veterinary internist and microbiologist, and a Diplomate of the American College of Veterinary Internal Medicine. He is an Associate Professor at the Ontario Veterinary College, University of Guelph and a Zoonotic Disease/Public health Microbiologist at the University of Guelph’s Centre for Public Health and Zoonoses. He is also Chief of Infection Control at the Ontario Veterinary College Teaching Hospital and holds a Canada Research Chair in zoonotic diseases. Dr. Weese has published over 140 papers in peer reviewed journals, edited two books and speaks extensively on infectious disease topics. His research interests are focused on zoonotic and antimicrobial resistant pathogens, particularly methicillin-resistant staphylococci and Clostridium difficile, infection control, emerging diseases and zoonotic disease risks with immunocompromised individuals.
Professor Dr. Hywel Williams BSc MSc PhD FRCP
State of the Art Lecture: Epidemiology of Human Atopic Dermatitis
Prof Williams directs the Centre of Evidence-Based Dermatology at the University of Nottingham which includes the Cochrane Skin Group and the UK Dermatology Clinical Trials Network. Prof Williams has a particular interest in childhood eczema and works as a clinical dermatologist at Nottingham, where he and his team run an award-winning eczema clinic. He has published over 300 peer-reviewed papers and is an advocate of evidence-based medicine and for working with healthcare users and within multidisciplinary teams to conduct high quality applied research that informs clinical practice. Prof Williams is Chair of the National Speciality Interest Group for Dermatology and is an NIHR Senior Investigator; he founded the Nottingham Clinical Trials Unit and played a key role in initiating the Centre of Evidence-Based Veterinary practice at Nottingham University. Outside of dermatology, he chairs the NIHR Health Technology Assessment Commissioning Board, which funds around £88 million on comparative effectiveness research each year.
State of the Art Lecture: Treatment of Skin Tumours
Prof David Argyle completed a PhD in oncology and immunology at the University of Glasgow Veterinary School and then joined the Department of Veterinary Clinical Studies as lecturer and then senior lecturer in clinical oncology and gene therapy. In 2002, he became head of veterinary oncology at the University of Wisconsin-Madison, USA. In 2005 he returned to the UK to be appointed to the William Dick Chair of veterinary clinical studies at the University of Edinburgh and the head of the veterinary oncology and companion animal stem cell programme. He is an RCVS and European recognized specialist in Veterinary Oncology, a Diplomat of the European College of Internal Medicine in Oncology and is the co-scientific editor of the Journal of Veterinary and Comparative Oncology. His current major research interests are cancer biology and cancer stem cells.
Professor Richard L. Gallo MD PhD
State of the Art Lecture: Antimicrobial Peptides and the Skin
Dr. Gallo is a Professor of Medicine and Pediatrics and Chief of the Division of Dermatology at the University of California-San Diego. His research focuses on the role of the innate immune system in skin health and disease, focusing on antimicrobial peptides and aspects of the basic functions of the skin immune system. Key contributions by his laboratory have included the first discovery of the existence of antimicrobial peptides in mammalian skin and the first demonstration that these are essential for immune defence of mammals. A common them throughout his work has been application of a wide range of modern biochemical and molecular techniques in experimental systems designed to uncover basic aspect of human immunity. Dr. Gallo has been President of the Society of VA Dermatologists and serves on the Board of Directors of the American Professors of Dermatology and the Society for Investigative Dermatology Journal.
Dr. Robert Harman DVM MPVM
State of the Art Lecture: Stem Cell Therapy in Veterinary Dermatology – Scientific Evidence and Clinical Approach
Dr. Harman received his DVM from the University of California at Davis in 1982 and also concurrently completed a Masters in Preventative Veterinary Medicine through the Department of Epidemiology, UC Davis. Dr. Harman practiced in production animal medicine in California from 1982-1985. He then founded HTI Bio-Services, a contract veterinary research company. From 1985-1999, he was the senior clinical investigator and CEO of HTI Bio-Services and authored more than 500 study reports in support of the FDA and USDA registration of pharmaceuticals, biologics and medical devices. In 2003 he founded Vet-Stem, a veterinary regenerative medicine company in California. Dr. Harman has been the author on six peer-reviewed stem cell publications in veterinary and human medicine and has spoken at over 100 domestic and international conferences on the science and clinical translation of regenerative medicine.
Dr. Koji Nishifuji DVM PhD Dip AICVD
State of the Art Lecture: SkinWars: Episode I - Rampart of Horny Layer in Mammalian Skin
Dr Nishifuji gained a PhD from the United Graduate School of Veterinary Sciences, Gifu University and became a postdoctoral research fellow in the Department of Dermatology, Keio University School of Medicine. From 2007 to 2009 he was a Senior Assistant Professor, Department of Veterinary Medicine, Tokyo University of Agriculture and Technology and is currently an Associate Professor at the same institution. He is a de facto specialist of the Asian College of Veterinary Dermatology and the current Vice President of the Asian Society of Veterinary Dermatology; an Executive Board Member of the Japanese Society of Veterinary Dermatology; an Editorial Board Member of Veterinary Dermatology and an Associate Editor of the Japanese Journal of Veterinary Dermatology. His areas of special interest in research include stratum corneum lipids and cutaneous barrier function in dogs; desmosomal adhesion and related-skin diseases in mammals and tissue regeneration of canine epidermis
Professor J Scott Weese DVM DVSc Dip ACVIM
State of the Art Lecture: The Skin Microbiome in Heath and Disease
Dr. Weese is a veterinary internist and microbiologist, and a Diplomate of the American College of Veterinary Internal Medicine. He is an Associate Professor at the Ontario Veterinary College, University of Guelph and a Zoonotic Disease/Public health Microbiologist at the University of Guelph’s Centre for Public Health and Zoonoses. He is also Chief of Infection Control at the Ontario Veterinary College Teaching Hospital and holds a Canada Research Chair in zoonotic diseases. Dr. Weese has published over 140 papers in peer reviewed journals, edited two books and speaks extensively on infectious disease topics. His research interests are focused on zoonotic and antimicrobial resistant pathogens, particularly methicillin-resistant staphylococci and Clostridium difficile, infection control, emerging diseases and zoonotic disease risks with immunocompromised individuals.
Professor Dr. Hywel Williams BSc MSc PhD FRCP
State of the Art Lecture: Epidemiology of Human Atopic Dermatitis
Prof Williams directs the Centre of Evidence-Based Dermatology at the University of Nottingham which includes the Cochrane Skin Group and the UK Dermatology Clinical Trials Network. Prof Williams has a particular interest in childhood eczema and works as a clinical dermatologist at Nottingham, where he and his team run an award-winning eczema clinic. He has published over 300 peer-reviewed papers and is an advocate of evidence-based medicine and for working with healthcare users and within multidisciplinary teams to conduct high quality applied research that informs clinical practice. Prof Williams is Chair of the National Speciality Interest Group for Dermatology and is an NIHR Senior Investigator; he founded the Nottingham Clinical Trials Unit and played a key role in initiating the Centre of Evidence-Based Veterinary practice at Nottingham University. Outside of dermatology, he chairs the NIHR Health Technology Assessment Commissioning Board, which funds around £88 million on comparative effectiveness research each year.